Literature DB >> 8095653

HTLV-II associated myelopathy in 43-year-old woman. REDS Investigators.

E L Murphy, J W Engstrom, K Miller, R A Sacher, M P Busch, C G Hollingsworth.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8095653     DOI： 10.1016/0140-6736(93)90529-p

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Complete nucleotide sequence of the new simian T-lymphotropic virus, STLV-PH969 from a Hamadryas baboon, and unusual features of its long terminal repeat.

Authors:  M Van Brüssel; P Goubau; R Rousseau; J Desmyter; A M Vandamme
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  HTLV-II infection in the Western United States.

Authors:  B Hjelle
Journal:  West J Med       Date:  1994-06

3.  Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.

Authors:  D Agranoff; K Varney; H Khayam-Bashi; E L Murphy
Journal:  West J Med       Date:  1996-06

4.  Prevalence of HTLV infection in pregnant women in Spain.

Authors:  A Machuca; C Tuset; V Soriano; E Caballero; A Aguilera; R Ortiz de Lejarazu
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

5.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

6.  Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.

Authors:  R Mahieux; C A Pise-Masison; P F Lambert; C Nicot; L De Marchis; A Gessain; P Green; W Hall; J N Brady
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression.

Authors:  M Giacomo; E G Franco; C Claudio; C Carlo; D A Anna; D Anna; F Franco
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

8.  Determinants of subject visit participation in a prospective cohort study of HTLV infection.

Authors:  Deborah A DeVita; Mary C White; Xin Zhao; Zhanna Kaidarova; Edward L Murphy
Journal:  BMC Med Res Methodol       Date:  2009-03-10       Impact factor: 4.615
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.